MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Cytosorbents Corporation Retained Earnings 2011-2025 | CTSO
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Cytosorbents Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -304 M | -283 M | -254 M | -221 M | -197 M | -189 M | -170 M | -152 M | -144 M | -133 M | -124 M | -106 M | -98.7 M | -92.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -92.6 M | -304 M | -176 M |
Quarterly Retained Earnings Cytosorbents Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -307 M | -304 M | -305 M | -304 M | -295 M | -293 M | -289 M | -283 M | -277 M | -267 M | -261 M | -254 M | -253 M | - | -230 M | -221 M | -212 M | -205 M | -201 M | -197 M | -197 M | -197 M | -197 M | -189 M | -189 M | -189 M | -189 M | -170 M | -170 M | -170 M | -170 M | -152 M | -152 M | -152 M | -152 M | -144 M | -144 M | -144 M | -144 M | -133 M | -133 M | -133 M | -133 M | -124 M | -124 M | -124 M | -124 M | -106 M | -106 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -106 M | -307 M | -196 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
828 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.47 | -3.61 % | $ 120 M | USA |
 |
Boston Scientific Corporation
BSX
|
2.67 B | $ 96.06 | -0.04 % | $ 141 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 9.35 | -1.99 % | $ 671 M |  Israel |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 303.76 | 0.52 % | $ 8.57 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 47.89 | -0.48 % | $ 7.14 K | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Abbott Laboratories
ABT
|
47.3 B | $ 124.72 | -0.1 % | $ 217 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.3 | 11.09 % | $ 123 M |  France |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
875 M | $ 14.62 | 1.04 % | $ 1.16 B | Israel |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.21 | 6.14 % | $ 19.5 M | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
LivaNova PLC
LIVN
|
-903 M | $ 62.92 | -0.25 % | $ 3.41 B |  Britain |
 |
Align Technology
ALGN
|
2.48 B | $ 158.62 | 0.49 % | $ 11.9 B | USA |
 |
NanoVibronix
NAOV
|
-69.8 M | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
-519 M | $ 0.83 | -3.49 % | $ 85.3 M | USA |
|
LENSAR
LNSR
|
-143 M | $ 12.03 | 0.17 % | $ 139 M | USA |
 |
IRadimed Corporation
IRMD
|
56.8 M | $ 97.53 | 0.48 % | $ 1.24 B | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-191 M | $ 14.04 | -3.13 % | $ 379 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 14.51 | -0.13 % | $ 95.1 M | USA |
 |
AxoGen
AXGN
|
-291 M | $ 32.87 | 0.7 % | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
560 M | $ 40.89 | 2.12 % | $ 1.26 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-236 M | $ 17.36 | -0.29 % | $ 401 M | USA |
 |
Globus Medical
GMED
|
1.15 B | $ 88.38 | -0.15 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 12.65 | -0.08 % | $ 974 M | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.58 | 3.61 % | $ 4.03 M | USA |
 |
Myomo
MYO
|
-88.8 M | $ 1.02 | - | $ 7.19 M | USA |